Thalys Medical Technology Group (SHSE:603716) Cyclically Adjusted Book per Share: ¥6.63 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603716 Thalys Medical Technology Group Corp SHSE:603716
39 GF Score
Price ¥15.89
GF Value ¥4.70
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Thalys Medical Technology Group Cyclically Adjusted Book per Share?

Thalys Medical Technology Group SHSE:603716 +3.38% 39 Cyclically Adjusted Book per Share is ¥6.63 as of Mar. 2026. GuruFocus rates SHSE:603716 with a GF Score™ of 39/100 and a GF Value™ of ¥4.70 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Thalys Medical Technology Group's adjusted book value per share for the three months ended in Mar. 2026 was ¥4.706. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥6.63 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Thalys Medical Technology Group's average Cyclically Adjusted Book Growth Rate was 0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-02), Thalys Medical Technology Group's current stock price is ¥15.89. Thalys Medical Technology Group's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥6.63. Thalys Medical Technology Group's Cyclically Adjusted PB Ratio of today is 2.40.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Thalys Medical Technology Group was 5.13. The lowest was 0.83. And the median was 2.17.


Thalys Medical Technology Group  (SHSE:603716) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Thalys Medical Technology Group's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.89/6.63
=2.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Thalys Medical Technology Group was 5.13. The lowest was 0.83. And the median was 2.17.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Thalys Medical Technology Group Cyclically Adjusted Book per Share Related Terms


Thalys Medical Technology Group Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Thalys Medical Technology Group's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thalys Medical Technology Group Cyclically Adjusted Book per Share Chart

Thalys Medical Technology Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 6.54 6.65

Thalys Medical Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.60 6.62 6.61 6.65 6.63

SHSE:603716 vs TMO, DHR, IDXX: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's Cyclically Adjusted PB Ratio falls into.


SHSE:603716
39GF Score
Thalys Medical Technology Group Corp SHSE:603716
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thalys Medical Technology Group Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thalys Medical Technology Group's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.706/116.3033*116.3033
=4.706

Current CPI (Mar. 2026) = 116.3033.

Thalys Medical Technology Group Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.716 101.400 4.262
201609 2.864 102.400 3.253
201612 4.732 102.600 5.364
201703 4.783 103.200 5.390
201706 4.917 103.100 5.547
201709 4.991 104.100 5.576
201712 5.235 104.500 5.826
201803 5.312 105.300 5.867
201806 7.638 104.900 8.468
201809 7.554 106.600 8.242
201812 7.445 106.500 8.130
201903 7.471 107.700 8.068
201906 7.664 107.700 8.276
201909 7.714 109.800 8.171
201912 7.259 111.200 7.592
202003 7.157 112.300 7.412
202006 7.277 110.400 7.666
202009 7.882 111.700 8.207
202012 8.036 111.500 8.382
202103 8.086 112.662 8.347
202106 7.815 111.769 8.132
202109 7.895 112.215 8.183
202112 7.619 113.108 7.834
202203 7.703 114.335 7.836
202206 7.570 114.558 7.685
202209 7.560 115.339 7.623
202212 6.892 115.116 6.963
202303 6.814 115.116 6.884
202306 6.876 114.558 6.981
202309 6.851 115.339 6.908
202312 5.992 114.781 6.071
202403 5.966 115.227 6.022
202406 5.586 114.781 5.660
202409 5.309 115.785 5.333
202412 4.892 114.893 4.952
202503 4.816 115.116 4.866
202506 4.589 114.907 4.645
202509 5.192 115.471 5.229
202512 4.494 115.832 4.512
202603 4.706 116.303 4.706

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥6.63 mean?
Thalys Medical Technology Group (SHSE:603716) has a Cyclically Adjusted Book per Share of ¥6.63 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Thalys Medical Technology Group and its competitors.
Is Thalys Medical Technology Group's Cyclically Adjusted Book per Share too high?
Thalys Medical Technology Group's current Cyclically Adjusted Book per Share is ¥6.63. Overall, Thalys Medical Technology Group has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Thalys Medical Technology Group's Cyclically Adjusted Book per Share compare to TMO and DHR?
Thalys Medical Technology Group's Cyclically Adjusted Book per Share of ¥6.63 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Thalys Medical Technology Group and its competitors. Thalys Medical Technology Group's current Cyclically Adjusted Book per Share is ¥6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thalys Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Thalys Medical Technology Group (SHSE:603716) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.70, compared to a current price of ¥15.89 — trading 238.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥6.63. Thalys Medical Technology Group's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Thalys Medical Technology Group (SHSE:603716), the current Cyclically Adjusted Book per Share is ¥6.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thalys Medical Technology Group (SHSE:603716) Overvalued in 2026?

Based on GuruFocus' analysis, Thalys Medical Technology Group stock appears to be overvalued. The current stock price of ¥15.89 is trading 238.1% above its estimated GF Value™ of ¥4.70. GuruFocus considers Thalys Medical Technology Group to be Significantly Overvalued.

Key valuation signals for SHSE:603716:

  • Cyclically Adjusted Book per Share: ¥6.63
  • GF Value™: ¥4.70 vs. price of ¥15.89 (238.1% above fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603716 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thalys Medical Technology Group Business Description

Address 1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
39GF Score

Get the complete analysis for SHSE:603716

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.89
Price
¥4.70
GF Value